Insys Therapeutics Inc (INSYQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2015 | 03-2015 | 12-2014 | 09-2014 | 06-2014 | |
| Sales | 80,200 | 67,692 | 63,479 | 58,281 | 55,696 |
| Cost of Goods | 8,305 | 6,375 | 5,860 | 5,390 | 6,555 |
| Gross Profit | 71,895 | 61,317 | 57,619 | 52,891 | 49,141 |
| Operating Expenses | 57,675 | 53,139 | 45,366 | 33,259 | 34,510 |
| Operating Income | 14,525 | 8,553 | 13,113 | 20,022 | 15,186 |
| Other Income | 135 | 125 | 65 | 43 | 26 |
| Pre-tax Income | 14,660 | 8,678 | 13,178 | 20,065 | 15,212 |
| Income Tax | 5,247 | 2,811 | 5,752 | 8,560 | 5,747 |
| Net Income Continuous | 9,413 | 5,867 | 7,426 | 11,505 | 9,465 |
| Net Income | $9,413 | $5,867 | $7,426 | $11,505 | $9,465 |
| EPS Basic Total Ops | 0.13 | 0.08 | 0.10 | 0.17 | 0.14 |
| EPS Basic Continuous Ops | 0.13 | 0.08 | 0.11 | 0.17 | 0.14 |
| EPS Diluted Total Ops | 0.12 | 0.08 | 0.10 | 0.16 | 0.13 |
| EPS Diluted Continuous Ops | 0.12 | 0.08 | 0.10 | 0.16 | 0.13 |
| EBITDA(a) | $16,092 | $9,922 | $14,269 | $20,626 | $15,770 |